BioPharma & HealthTech Competitive Strategy & Insights | Digital & AI Solutions | Gene & Cell Therapy | Vaccines
FDA eases cancer drug shortages by working with manufacturers >>> lqventures.com #strategy #competitiveintelligence #marketing #healthcare #biotech #pharmaceutical #pharma #productmarketing
During Sickle Cell Awareness Month, we dive into the fascinating history and current insights on Sickle Cell Disease (SCD) Read our latest blog to discover how this hereditary blood condition was first uncovered and how it affects individuals today. Thank you to the Equality, Diversity & Inclusion Committee and Emilia Hurd for this fantastic piece Read more at: https://bit.ly/45frMgM #SickleCellDisease #MedicalHistory #BloodDonation #ResearchInProgress #sicklecellMonth #sicklecellawarenesscampaign #sicklecellawareness #campaign #innovativetrials #patients #patientaccess #patientrecruitment #clinicaltrials #clinicalresearch #pharmaindustry #pharma #pharmaceutical #awarenessmatters #raredisease
BioPharma & HealthTech Competitive Strategy & Insights | Digital & AI Solutions | Gene & Cell Therapy | Vaccines
FDA roundup: Final guidance on the fastest oncology drug approvals; Remote inspections fail to take off >>> lqventures.com #strategy #competitiveintelligence #marketing #healthcare #pharmaceutical #productmarketing #biotech #pharma
FDA roundup: Final guidance on the fastest oncology drug approvals; Remote inspections fail to take off >>> lqventures.com #strategy #competitiveintelligence #marketing #pharma #pharmaceutical #healthcare #biotech #productmarketing
Employee Benefits Consultant at USI Insurance Services | Advising on Capital-Efficient Insurance and Benefit Planning
More good news when it comes to employers managing prescription drug costs and employees saving money. Duexis manufacturing has been discontinued! When employers are seeing renewal increases due to high prescription claims, this drug could partially be to blame. Duexis is, simply stated, a combination of famotidine (AKA Pepcid) & Ibuprofen primarily used to treat RA and Osteoarthritis patients. The retail cost for Duexis is around $3,000!! That equates to approximately a 6600% increase from purchasing the famotidine and Ibuprofen separately. At USI, we strive for transparency in drug costs for our clients and this is one drug we previously identified as a red flag. Contact me for more information on how I can help your employer save money with our innovative, proprietary, solutions. [email protected] / 864-901-2244 What are your thoughts about this?
Drug-Coated Balloon for In-Stent Restenosis Treatment by Boston Scientific Gets from FDA Green Light Boston Scientific has received FDA approval for its drug-coated balloon to treat in-stent restenosis, a condition where a stented artery narrows again due to plaque buildup or scar tissue. This approval is significant because coronary artery disease (CAD) remains a leading cause of death worldwide, and current treatment options for in-stent restenosis have limitations. The Agent balloon, coated with paclitaxel, demonstrated effectiveness in a study and is expected to become a significant player in the global market, potentially worth $500 million. The approval marks a significant advancement in treating in-stent restenosis and offers new hope for patients. For more details please click the link! https://lnkd.in/dARU6_p4 #marketaccess #reimbursement #pricing #hta #heor #healtheconomics #medicaldevices #pharmaceutical
One in 17 people is affected by a #raredisease in Europe. With up to 8,000 identified rare conditions, diagnosis (and misdiagnosis) are all too common. As we advance support for sites and foster greater connections from medical to commercial, we will make faster leaps forward in rare disease research and education. https://bit.ly/49VAWBN #RareDiseaseDay European Pharmaceutical Manufacturer
Amylyx Pharmaceuticals' ALS drug, Relyvrio, didn't meet its goals in the crucial Phase III trial, casting uncertainty on its future. Despite this, the drug's safety profile remained consistent. Considerations - 🔹 The impact on ALS treatment advancements and patient hope. 🔹 Potential regulatory discussions and the commitment to patient well-being may guide Amylyx's next steps. This setback in ALS research emphasizes the challenges in neurodegenerative disease treatment but also the unwavering quest for solutions. #ALS #HealthcareNews #ClinicalTrials
Struggling with retention in pediatric studies? Join us at SCOPE, where we'll reveal our groundbreaking partnership designed to tackle pediatric retention challenges in clinical trials! 🌐✨🤝 See you there! Kate Shaw, Marco Lassandro, Eloise Moffett, Oliver Patch Project #innovativetrials #patients #patientaccess #clinicalresearch #pharmaindustry #pharma #pharmaceutical #SCOPE #SCOPE2024 #SCOPEsummit #clinicaltrials.
Read our case study to learn how MERIT’s spirometry expertise and quality overreads laid the foundation for a successful multi-study #COPD drug development program. https://lnkd.in/gGkU-6bn #clinicaltrials #clinicalresearch #respiratory #drugdevelopment #MERITCRO #YourClinicalEndpointExpert #spirometry #ChronicObstructivePulmonaryDisease
